The DETOUR 2 Clinical Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 202 participants.
Also called NCT03119233
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 202 participants
- Sponsor
- Registry
-
NCT03119233
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Germany, Latvia
- Registry status
- Completed
Technical summary
Registry record NCT03119233. Allocation not applicable; no masking; primary purpose treatment. Start 2017-12-13 (actual); primary completion 2021-12-22 (actual). Results posted on 2025-04-02.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The DETOUR 2 Clinical Trial
- Condition
- Peripheral Arterial Disease
- Intervention (Device)
- DETOUR System
- Lead sponsor
- Endologix
Record details
- Record id
cardio:ct-nct03119233- Content hash
7e9b230e4f6275536101fd2846632a1d094fc3823cf7e0dd7ac39e8d6df15e82